Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET
Company Participants
Susan Morrison - EVP and Chief Administrative Officer
John Sheridan - President and Chief Executive Officer
Leigh Vosseller - EVP and Chief Financial Officer
Conference Call Participants
Steve Lichtman - Oppenheimer & Co
Brooks O'Neil - Lake Street Capital
Alex Nowak - Craig-Hallum Capital
Jayson Bedford - Raymond James
Danielle Antalffy - SVB Securities
Jeff Johnson - Baird
Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
Operator
00:04 Thank you for standing by, and welcome to Tandem's First Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speaker presentation there will be a question-and-answer session. [Operator Instructions] Please be aware that today’s call is being recorded. [Operator Instructions]
00:29 I would now like to turn the call over to Susan Morrison, EVP and Chief Administrative Officer.
Susan Morrison
00:44 Thanks, and good afternoon everyone. Welcome to Tandem's 2022 first quarter earnings call.
00:50 Today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, product development timelines and financial performance and operating plans and speak only as of today's date. There are risks and uncertainties that could cause our actual results to differ materially from those anticipated or projected in our forward-looking statements. A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in our press release issued earlier today and under the Risk Factors portion and elsewhere in our most recent annual report on Form 10-K, quarterly report on Form 10-Q and in our other SEC filings. We assume no obligation to publicly update any forward-looking statements whether as a result of new information, future events or other factors.
01:44 In addition, today's discussion will include references to adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is a key measure used by us to evaluate operating performance, generate future operating plans and make strategic decisions for the allocation of capital. Please refer to our press release issued earlier today for further information.